Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACACIA: Amoxicillin-clavulanate in Low-Risk Febrile Neutropenia
NCT04698057Phase 3Withdrawn
- Sponsor
- CHU de Poitiers
- Start
- Mar 2022
- Primary completion
- Jun 2025
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of amoxicillin + clavulanate in febrile neutropenia (FN), sponsored by CHU de Poitiers. Planned start Mar 2022; status: withdrawn.
02
Drugs
amoxicillin + clavulanate
03
Conditions
febrile neutropenia (FN)
Beyond the preview
Go deeper on NCT04698057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04698057.